AtriCure Reports Resignation of Chief Executive Officer
16:05 EDT 2 Aug 2012 | Businesswire
This article has expired, however you can still
download the PDF.
Preview:
AtriCure, Inc. (Nasdaq: ATRC), a medical device company and a leader in
cardiac surgical ablation systems for the treatment of atrial
fibrillation, or AF, and systems for the exclusion of the left atrial
appendage, today announc...
Other Sources for this Article
AtriCure, Inc.
David J. Drachman, 513-755-5758
President and
Chief Executive Officer
ddrachman@atricure.com
More From BioPortfolio on "AtriCure Reports Resignation of Chief Executive Officer"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
